The effect of exercise exercises on heart failure patient

The study of effect of 8 weeks of exercise training on The most common aggravating factors of heart failure patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017070534911N1

Enrollment

Registered

2017-07-18

Start date

2017-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure. Congestive heart disease

Interventions

Intervention 1: Intervention group: How to exercise sports interventions In the test group, that is For 8 weeks, 2 times a week for 30 minutes of treadmill, Then, the Arm ergometer first started for 3

Rehabilitation

Intervention group: How to exercise sports interventions In the test group, that is For 8 weeks, 2 times a week for 30 minutes of treadmill, Then, the Arm ergometer first started for 3 minutes and up

Control group: There is no intervention

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:The age range40-70 years; with II, III grade heart failure ; patient with the most important aggravating factors including kidney, lung, diabetes and hypertension difficulties Exclusion criteria: :Exacerbation of heart failure symptoms; arrhythmia ; ischemic ; HTN crisis; Psychiatric problem;orthopedic problem; speech problem; hearing problem

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Lung volume In the intervention group. Timepoint: Before and after 8 weeks of exercise training. Method of measurement: spirometry.;Lung Volume In the control group. Timepoint: Before and 8 weeks After the start of the study. Method of measurement: Spirometry.;Lung capacity In the intervention group. Timepoint: Before and 8 weeks after exercise training. Method of measurement: spirometry.;Function and structure of the heart include: LVEF left ventricular fraction (%), systolic ending volume (ESV) and diastolic end volume (EDV). Timepoint: before and after 8 weeks of exercise training. Method of measurement: Echocardiogaphy.;Heart Rate. Timepoint: before and after of 8 week. Method of measurement: Pulseoximeter.;Blood Pressure. Timepoint: before and after of 8 weeks of exercise training. Method of measurement: pressure indicator.;Cr(Creatine Blood). Timepoint: before and after 8 weeks of exercise training. Method of measurement: Blood Test.;Potency function. Timepoint: before and after 8 weeks of exercise training. Method of measurement: 6-minute test.;HDL, LDL. Timepoint: before and after 8 weeks of exercise training. Method of measurement: Blood test.;BS? HbA1C. Timepoint: before and after 8 weeks of exercise training. Method of measurement: Blood Test.;Lung capacity In the controlgroup. Timepoint: before and 8 week After the start of the study. Method of measurement: Spirometry.;Blood Pressure in the control group. Timepoint: before and 8 week After the start of the study. Method of measurement: pressure indicator.;Cr(cratinine Blood) in the control group. Timepoint: before and 8 week After the start of the study. Method of measurement: Blood Test.;Heart rate in the control group. Timepoint: before and 8 week After the start of the study. Method of measurement: pulseoximetry.;Potency function in the control group. Timepoint: before and 8 week After the start of the study. Method of measurement: 6 minute test.;HDL, LDL Blood in the control group. Timepoint: before	—

Measure

Time frame

Lung volume In the intervention group. Timepoint: Before and after 8 weeks of exercise training. Method of measurement: spirometry.;Lung Volume In the control group. Timepoint: Before and 8 weeks After the start of the study. Method of measurement: Spirometry.;Lung capacity In the intervention group. Timepoint: Before and 8 weeks after exercise training. Method of measurement: spirometry.;Function and structure of the heart include: LVEF left ventricular fraction (%), systolic ending volume (ESV) and diastolic end volume (EDV). Timepoint: before and after 8 weeks of exercise training. Method of measurement: Echocardiogaphy.;Heart Rate. Timepoint: before and after of 8 week. Method of measurement: Pulseoximeter.;Blood Pressure. Timepoint: before and after of 8 weeks of exercise training. Method of measurement: pressure indicator.;Cr(Creatine Blood). Timepoint: before and after 8 weeks of exercise training. Method of measurement: Blood Test.;Potency function. Timepoint: before and after 8 weeks of exercise training. Method of measurement: 6-minute test.;HDL, LDL. Timepoint: before and after 8 weeks of exercise training. Method of measurement: Blood test.;BS? HbA1C. Timepoint: before and after 8 weeks of exercise training. Method of measurement: Blood Test.;Lung capacity In the controlgroup. Timepoint: before and 8 week After the start of the study. Method of measurement: Spirometry.;Blood Pressure in the control group. Timepoint: before and 8 week After the start of the study. Method of measurement: pressure indicator.;Cr(cratinine Blood) in the control group. Timepoint: before and 8 week After the start of the study. Method of measurement: Blood Test.;Heart rate in the control group. Timepoint: before and 8 week After the start of the study. Method of measurement: pulseoximetry.;Potency function in the control group. Timepoint: before and 8 week After the start of the study. Method of measurement: 6 minute test.;HDL, LDL Blood in the control group. Timepoint: before

—

Secondary

Measure	Time frame
Cardiac arrhythmia. Timepoint: During the exercise. Method of measurement: manitoring.;Ischemia. Timepoint: During the exercise. Method of measurement: manitoring.;HTN crisis. Timepoint: By indication symptoms. Method of measurement: pressure indicator.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Mahmoodi

Guilan Guilan University of Medical Sciences

gicrc@gums.ac.irfzmahmoodi@yahoo.comfmahmoodi1390@gmail.com+98 133366906466

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026